AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33783516 — intervention group
Group type: EXPERIMENTAL
Intervention: Shortened duration of adjuvant chemotherapy (3 to 5 months) with CAPOX (capecitabine plus oxaliplatin)
Number of subjects: 485
Study 33783516 — intervention group
Group type: COMPARATOR
Intervention: Shortened duration of adjuvant chemotherapy (3 to 5 months) with FOLFOX (5-fluorouracil/leucovorin plus oxaliplatin)
Number of subjects: 485
Study 32800642 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper-extremity manipulation
Number of subjects: 0
Study 32800642 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-extremity manipulation
Number of subjects: 0
Study 32800642 — intervention group
Group type: COMPARATOR
Intervention: Control (no manipulation)
Number of subjects: 0
Study 32208884 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate plus placebo, Citalopram plus placebo, Citalopram plus Methylphenidate
Number of subjects: 165
Study 32208884 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram combined with Tai Chi or health education
Number of subjects: 165
Study 33210651 — intervention group
Group type: EXPERIMENTAL
Intervention: Essential drugs prescribed
Number of subjects: 2200
Study 33210651 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics prescribed
Number of subjects: 2200
Study 33210651 — intervention group
Group type: EXPERIMENTAL
Intervention: Medicines prescribed in generic names
Number of subjects: 2200
Study 33210651 — intervention group
Group type: EXPERIMENTAL
Intervention: Adequate response on medicine use
Number of subjects: 2200
Study 37071202 — intervention group
Group type: COMPARATOR
Intervention: Conventional exercise program (Control)
Number of subjects: 36
Study 32498613 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological inoculation (PI)
Number of subjects: 149
Study 32498613 — intervention group
Group type: COMPARATOR
Intervention: Control (education)
Number of subjects: 149
Study 33137137 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Breastfeeding Performance Index (BPI) scores
Number of subjects: 605
Study 33137137 — intervention group
Group type: EXPERIMENTAL
Intervention: Living alone
Number of subjects: 605
Study 33137137 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal occupation as merchants
Number of subjects: 605
Study 33137137 — intervention group
Group type: EXPERIMENTAL
Intervention: Attended three antenatal care (ANC) visits
Number of subjects: 605
Study 33137137 — intervention group
Group type: EXPERIMENTAL
Intervention: Attended four antenatal care visits
Number of subjects: 605
Study 33137137 — intervention group
Group type: EXPERIMENTAL
Intervention: Received postnatal care (PNC)
Number of subjects: 605
Study 33137137 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor knowledge on breastfeeding
Number of subjects: 605
Study 33137137 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative attitudes towards breastfeeding
Number of subjects: 605
Study 36226787 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-directed arm (0-30 tablets of oxycodone 5 mg)
Number of subjects: 73
Study 36226787 — intervention group
Group type: COMPARATOR
Intervention: Standard arm (30 tablets of oxycodone 5 mg)
Number of subjects: 73
Study 32167957 — intervention group
Group type: EXPERIMENTAL
Intervention: arm + hand contralaterally controlled functional electrical stimulation
Number of subjects: 67
Study 35035944 — intervention group
Group type: EXPERIMENTAL
Intervention: SNF472 (7 mg/kg intravenously) three times weekly for 12 weeks
Number of subjects: 66
Study 35035944 — intervention group
Group type: COMPARATOR
Intervention: Placebo three times weekly for 12 weeks
Number of subjects: 66
Study 33336834 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended trading hours
Number of subjects: 0
Study 33336834 — intervention group
Group type: COMPARATOR
Intervention: Control policies
Number of subjects: 0
Study 33126364 — intervention group
Group type: EXPERIMENTAL
Intervention: Competence training for ASHA workers over 6 months
Number of subjects: 0
Study 33126364 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline competence assessment using a questionnaire and practical evaluation
Number of subjects: 0
Study 34906376 — intervention group
Group type: EXPERIMENTAL
Intervention: veliparib (throughout)
Number of subjects: 1140
Study 34906376 — intervention group
Group type: EXPERIMENTAL
Intervention: veliparib (pooled arms)
Number of subjects: 1140
Study 33595213 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly telephone calls by a clinical dietitian for 3 months
Number of subjects: 22
Study 33595213 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 22
Study 32910720 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphological vocabulary intervention
Number of subjects: 111
Study 32910720 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic assessment of morphological analysis
Number of subjects: 111
Study 32910720 — intervention group
Group type: EXPERIMENTAL
Intervention: Static assessment of morphological analysis
Number of subjects: 111
Study 33955190 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy plus intensity-modulated radiotherapy (IC+RT)
Number of subjects: 204
Study 33955190 — intervention group
Group type: COMPARATOR
Intervention: Concurrent chemotherapy plus IMRT (CCRT)
Number of subjects: 204
Study 32579549 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplement containing 2.6g of amino acids and 250 mcg of chromium picolinate
Number of subjects: 60
Study 32579549 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 34006256 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional logistic model with radiologic grouping for predicting RMPP-3
Number of subjects: 716
Study 34006256 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional logistic model with radiologic grouping plus laboratory values for predicting RMPP-3
Number of subjects: 716
Study 34006256 — intervention group
Group type: EXPERIMENTAL
Intervention: Laboratory values or radiologic grouping for predicting RMPP-5
Number of subjects: 716
Study 34006256 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction models using predefined fever profiles for predicting RMPP-5
Number of subjects: 716
Study 34006256 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural network models using 12 sequential fever data for predicting RMPP-5
Number of subjects: 716
Study 32873500 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone
Number of subjects: 570
Study 32873500 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual buprenorphine–naloxone
Number of subjects: 570
Study 32873500 — intervention group
Group type: COMPARATOR
Intervention: Control group (older adults aged ≥26 years)
Number of subjects: 570
Study 34793521 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid training system (HTS) during knee bending exercise
Number of subjects: 10
Study 33801665 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot Juice (BJ) 140 mL (12.8 mmol NO3−)
Number of subjects: 11
Study 33801665 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot Juice (BJ)
Number of subjects: 11
Study 33801665 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 11
Study 32405071 — intervention group
Group type: EXPERIMENTAL
Intervention: Continued ACEI/ARB treatment
Number of subjects: 500
Study 32405071 — intervention group
Group type: COMPARATOR
Intervention: Temporary discontinuation of ACEI/ARB treatment for 30 days
Number of subjects: 500
Study 36383269 — intervention group
Group type: EXPERIMENTAL
Intervention: Tandospirone
Number of subjects: 0
Study 36383269 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36383269 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers
Number of subjects: 0
Study 33098159 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural Activation (BA) intervention
Number of subjects: 309
Study 33098159 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 309
Study 32955913 — intervention group
Group type: EXPERIMENTAL
Intervention: Triphala (2,000 mg daily for 4 weeks)
Number of subjects: 31
Study 32955913 — intervention group
Group type: EXPERIMENTAL
Intervention: Manjistha (2,000 mg daily for 4 weeks)
Number of subjects: 31
Study 32955913 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2,000 mg daily for 4 weeks)
Number of subjects: 31
Study 36220197 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive resistance training (PRT) plus weight loss (WL) (hypocaloric diet)
Number of subjects: 36
Study 36220197 — intervention group
Group type: COMPARATOR
Intervention: Weight loss (WL) plus sham (stretching)
Number of subjects: 36
Study 34610941 — intervention group
Group type: EXPERIMENTAL
Intervention: HABIT-ILE therapy
Number of subjects: 40
Study 34610941 — intervention group
Group type: COMPARATOR
Intervention: High intensity conventional therapy
Number of subjects: 40
Study 32814489 — intervention group
Group type: EXPERIMENTAL
Intervention: Free-breathing CTPA
Number of subjects: 240
Study 32814489 — intervention group
Group type: COMPARATOR
Intervention: Breath-holding CTPA
Number of subjects: 240
Study 35666875 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccination of chickens against Newcastle disease
Number of subjects: 0
Study 35666875 — intervention group
Group type: COMPARATOR
Intervention: Control (no vaccination)
Number of subjects: 0
Study 32459653 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily text message reminders, feedback, and gain-framed nominal financial incentives (Arm 1)
Number of subjects: 125
Study 32459653 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily text message reminders and feedback only (Arm 2)
Number of subjects: 125
Study 32459653 — intervention group
Group type: COMPARATOR
Intervention: No reminders, feedback, or incentives (Arm 3)
Number of subjects: 125
Study 35596530 — intervention group
Group type: EXPERIMENTAL
Intervention: ACTT (Asthma Care Transition Team)
Number of subjects: 60
Study 35596530 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 60
Study 35596530 — intervention group
Group type: EXPERIMENTAL
Intervention: ACTT
Number of subjects: 60
Study 33637110 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative Exposure Therapy (NET)
Number of subjects: 0
Study 33637110 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 0
Study 36232176 — intervention group
Group type: EXPERIMENTAL
Intervention: N95-mask
Number of subjects: 19
Study 36232176 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical mask (SM)
Number of subjects: 19
Study 36232176 — intervention group
Group type: COMPARATOR
Intervention: No mask (NM)
Number of subjects: 19
Study 36232176 — intervention group
Group type: EXPERIMENTAL
Intervention: All conditions (N95, SM, NM)
Number of subjects: 19
Study 32538106 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation
Number of subjects: 58
Study 32538106 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound-guided non-flush ligation and stripping of the great saphenous vein
Number of subjects: 58
Study 35113605 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based organizations and community clinics screening for mental health symptoms
Number of subjects: 1057
Study 33319467 — intervention group
Group type: EXPERIMENTAL
Intervention: Cox regression models for predicting ESRD risk
Number of subjects: 141516
Study 33319467 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomograms and charts developed from selected variables
Number of subjects: 141516
Study 35367159 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital guide for IMFS implantation
Number of subjects: 40
Study 35367159 — intervention group
Group type: COMPARATOR
Intervention: Control group (IMFS implanted based on clinical experience)
Number of subjects: 40
Study 33111581 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice bran (30 g/day) plus navy bean (30 g/day)
Number of subjects: 20
Study 33111581 — intervention group
Group type: COMPARATOR
Intervention: Fibersol‐2® (10 g/day)
Number of subjects: 20
Study 35286527 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser–activated irrigation with self-etching mode
Number of subjects: 60
Study 35286527 — intervention group
Group type: COMPARATOR
Intervention: Passive ultrasonic irrigation (positive control) with self-etching mode
Number of subjects: 60
Study 35286527 — intervention group
Group type: COMPARATOR
Intervention: Conventional syringe irrigation (negative control) with total-etching mode
Number of subjects: 60
Study 36361500 — intervention group
Group type: EXPERIMENTAL
Intervention: Capacitive‐Resistive Electric Transfer (CRET)
Number of subjects: 6
Study 36361500 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 36361500 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 6
Study 34370125 — intervention group
Group type: EXPERIMENTAL
Intervention: High Ligation (HL)
Number of subjects: 22
Study 34370125 — intervention group
Group type: COMPARATOR
Intervention: Low Ligation (LL)
Number of subjects: 22
Study 33677037 — intervention group
Group type: EXPERIMENTAL
Intervention: School-level factors
Number of subjects: 26885
Study 33677037 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive school climate
Number of subjects: 26885
Study 33677037 — intervention group
Group type: EXPERIMENTAL
Intervention: Urban location and higher percentage of free school meals and White British
Number of subjects: 26885
Study 32219705 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback about personal QoL results (WHOQOL-BREF and WHOQOL importance measures)
Number of subjects: 107
Study 32219705 — intervention group
Group type: COMPARATOR
Intervention: Assessment of QoL without feedback
Number of subjects: 107
Study 33125288 — intervention group
Group type: EXPERIMENTAL
Intervention: Callous-Unemotional traits
Number of subjects: 289
Study 33125288 — intervention group
Group type: EXPERIMENTAL
Intervention: Conduct Problems
Number of subjects: 289
Study 33714863 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand massage
Number of subjects: 82
Study 33714863 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot massage
Number of subjects: 82
Study 33714863 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard nursing interventions only)
Number of subjects: 82
Study 32495698 — intervention group
Group type: EXPERIMENTAL
Intervention: Gardening
Number of subjects: 16
Study 32495698 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 16
Study 36365080 — intervention group
Group type: EXPERIMENTAL
Intervention: Ablative fractional laser-assisted delivery of methotrexate (AFL+MTX) therapy
Number of subjects: 22
Study 36365080 — intervention group
Group type: COMPARATOR
Intervention: Ablative fractional laser (AFL) therapy
Number of subjects: 22
Study 33017065 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 53
Study 33017065 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (Control)
Number of subjects: 53
Study 33609344 — intervention group
Group type: EXPERIMENTAL
Intervention: Qigong exercise (QG, n = 20)
Number of subjects: 41
Study 33609344 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG, n = 21)
Number of subjects: 41
Study 33593096 — intervention group
Group type: EXPERIMENTAL
Intervention: ‘Be Sweet to Babies' videos and a tip sheet
Number of subjects: 151
Study 33593096 — intervention group
Group type: EXPERIMENTAL
Intervention: As per Group 1 plus a motivational interviewing informed Affirmative Statements and Questions (AS&Q)
Number of subjects: 151
Study 32629392 — intervention group
Group type: EXPERIMENTAL
Intervention: CD133+ bone marrow derived hematopoietic stem cells
Number of subjects: 37
Study 32629392 — intervention group
Group type: EXPERIMENTAL
Intervention: SH2B3/LNK-silenced hematopoietic stem cell (HSC) clones
Number of subjects: 37
Study 32629392 — intervention group
Group type: EXPERIMENTAL
Intervention: SH2B3/LNK knockout mice
Number of subjects: 37
Study 32629392 — intervention group
Group type: EXPERIMENTAL
Intervention: Biomarker signature prediction
Number of subjects: 37
Study 32505710 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention for 6 months
Number of subjects: 78
Study 32505710 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 78
Study 33321509 — intervention group
Group type: EXPERIMENTAL
Intervention: Body in Mind Training (BMT)
Number of subjects: 249
Study 33321509 — intervention group
Group type: COMPARATOR
Intervention: Quality of Life and Psychoeducation (QoL)
Number of subjects: 249
Study 33321509 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine (FLX)
Number of subjects: 249
Study 35613766 — intervention group
Group type: EXPERIMENTAL
Intervention: Statins alone or in combination with ezetimibe or proprotein convertase subtilisin/kexin type 9 inhibitors
Number of subjects: 100
Study 33939245 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mcg of budesonide daily for 3 months
Number of subjects: 180
Study 33939245 — intervention group
Group type: COMPARATOR
Intervention: Placebo daily for 3 months
Number of subjects: 180
Study 34393202 — intervention group
Group type: EXPERIMENTAL
Intervention: Analgesic treatment
Number of subjects: 10
Study 34393202 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 33794830 — intervention group
Group type: EXPERIMENTAL
Intervention: Noise sensitivity
Number of subjects: 500
Study 33794830 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocturnal noise
Number of subjects: 500
Study 32872953 — intervention group
Group type: EXPERIMENTAL
Intervention: Method for delivering arbitrarily polarized light using a standard optical fiber.
Number of subjects: 0
Study 32872953 — intervention group
Group type: EXPERIMENTAL
Intervention: Method for delivering randomly selected elliptical states through a standard fiber.
Number of subjects: 0
Study 36143240 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 60
Study 36143240 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 60
Study 33782879 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis (H)
Number of subjects: 60
Study 33782879 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive Muscle Relaxation (PMR)
Number of subjects: 60
Study 33782879 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 60
Study 35276932 — intervention group
Group type: EXPERIMENTAL
Intervention: CAF + CA
Number of subjects: 20
Study 35276932 — intervention group
Group type: EXPERIMENTAL
Intervention: CAF + NoCA
Number of subjects: 20
Study 35276932 — intervention group
Group type: COMPARATOR
Intervention: PL + CA
Number of subjects: 20
Study 34342007 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol
Number of subjects: 36
Study 34342007 — intervention group
Group type: COMPARATOR
Intervention: Nonalcoholic control beverage
Number of subjects: 36
Study 35513132 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton therapy (PT)
Number of subjects: 4
Study 35513132 — intervention group
Group type: COMPARATOR
Intervention: Photon therapy (XT)
Number of subjects: 4
Study 34967333 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D-printed tooth model
Number of subjects: 145
Study 34967333 — intervention group
Group type: COMPARATOR
Intervention: Control group (no obturation with the model)
Number of subjects: 145
Study 35319298 — intervention group
Group type: EXPERIMENTAL
Intervention: Masked faces
Number of subjects: 199
Study 35319298 — intervention group
Group type: COMPARATOR
Intervention: Unmasked faces
Number of subjects: 199
Study 35319298 — intervention group
Group type: EXPERIMENTAL
Intervention: Both conditions
Number of subjects: 199
Study 33141635 — intervention group
Group type: EXPERIMENTAL
Intervention: Yellow passion fruit albedo flour (FAMA) 500 mg capsules, three times a day
Number of subjects: 89
Study 33141635 — intervention group
Group type: EXPERIMENTAL
Intervention: Long turmeric capsules (CURPI) 500 mg merged with piperine (5 mg)
Number of subjects: 89
Study 33141635 — intervention group
Group type: COMPARATOR
Intervention: Placebo of carboxymethyl cellulose (500 mg)
Number of subjects: 89
Study 36071998 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal hand‐sewn side‐to‐side isoperistaltic ileocolic anastomosis (EHSIA)
Number of subjects: 54
Study 36071998 — intervention group
Group type: COMPARATOR
Intervention: Intracorporeal mechanic side‐to‐side isoperistaltic ileocolic anastomosis (IMSIA)
Number of subjects: 54
Study 36071998 — intervention group
Group type: COMPARATOR
Intervention: Comparison of both groups
Number of subjects: 54
Study 32144378 — intervention group
Group type: EXPERIMENTAL
Intervention: Calorie restriction (CR) aiming for 25% reduction for 2 years
Number of subjects: 143
Study 35617704 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (Lactobacillus rhamnosus GG; L.GG)
Number of subjects: 127
Study 35617704 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 127
Study 33369552 — intervention group
Group type: EXPERIMENTAL
Intervention: Music video with powered toothbrush
Number of subjects: 60
Study 33369552 — intervention group
Group type: COMPARATOR
Intervention: Control group with powered toothbrush
Number of subjects: 60
Study 33369552 — intervention group
Group type: EXPERIMENTAL
Intervention: Hourglass timer with manual toothbrush
Number of subjects: 60
Study 33369552 — intervention group
Group type: EXPERIMENTAL
Intervention: Music video with manual toothbrush
Number of subjects: 60
Study 33369552 — intervention group
Group type: EXPERIMENTAL
Intervention: Hourglass timer with powered toothbrush
Number of subjects: 60
Study 33369552 — intervention group
Group type: COMPARATOR
Intervention: Control group with manual toothbrush
Number of subjects: 60
Study 36096175 — intervention group
Group type: EXPERIMENTAL
Intervention: Maralixibat
Number of subjects: 27
Study 33973161 — intervention group
Group type: EXPERIMENTAL
Intervention: Barrier enclosure
Number of subjects: 94
Study 33973161 — intervention group
Group type: COMPARATOR
Intervention: Control (no barrier enclosure)
Number of subjects: 94
Study 33034421 — intervention group
Group type: EXPERIMENTAL
Intervention: Nuvaring®
Number of subjects: 130
Study 33034421 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection
Number of subjects: 130
Study 33034421 — intervention group
Group type: EXPERIMENTAL
Intervention: COC
Number of subjects: 130
Study 33034421 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall preference
Number of subjects: 130
Study 33034421 — intervention group
Group type: COMPARATOR
Intervention: Nuvaring® vs Injection
Number of subjects: 130
Study 33034421 — intervention group
Group type: COMPARATOR
Intervention: Nuvaring® vs COC
Number of subjects: 130